Evosep

Odense, Denmark

Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster.

$40.0M raised

Jan 2023

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Evosep raised?

Evosep has raised $40.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2023.

Who are Evosep's investors?

Evosep's investors include Novo Holdings, Vaekstfonden.

Where is Evosep headquartered?

Evosep is headquartered in Odense, Denmark.

What does Evosep do?

Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster.

What stage is Evosep at?

Evosep is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 9, 2023.

MLA

"Evosep — Funding & Investors." VCBacked, January 9, 2023, https://www.vcbacked.co/company/evosep. Accessed July 2, 2026.

APA

VCBacked. (2023). Evosep — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/evosep

Wikipedia (cite web)

{{cite web |title=Evosep — Funding & Investors |url=https://www.vcbacked.co/company/evosep |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 9, 2023.